Vanguard Group Inc Lucira Health, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.11 - $0.83 $910 - $6,871	-8,279 Reduced 1.31%	623,488 $68,000
Q1 2022 May 13, 2022	BUY	$2.86 - $8.83 $342,996 - $1.06 Million	119,929 Added 23.43%	631,767 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$4.94 - $8.94 $313,116 - $566,652	63,384 Added 14.13%	511,838 $4.41 Million
Q3 2021 Nov 12, 2021	BUY	$6.05 - $10.81 $124,025 - $221,605	20,500 Added 4.79%	448,454 $3.41 Million
Q2 2021 Aug 13, 2021	BUY	$4.56 - $11.45 $1.95 Million - $4.9 Million	427,954 New	427,954 $2.84 Million

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.